First Page | Document Content | |
---|---|---|
Date: 2014-12-11 13:07:15Gilead Sciences Fixed dose combination Organofluorides Cyclopropanes Antiretroviral drug Efavirenz Reverse-transcriptase inhibitor Emtricitabine Abacavir Chemistry Organic chemistry Non-nucleoside reverse transcriptase inhibitors | How to use this document:Add to Reading ListSource URL: www.vdh.state.va.usDownload Document from Source WebsiteFile Size: 148,53 KBShare Document on Facebook |
DEPARTMENT OF BIOCHEMISTRY FRONTIERS PROFESSOR KENNETH JOHNSON Roger J. Williams Centennial Professor of Biochemistry, University of Texas, USA DATEDocID: 1pw8Q - View Document | |
Human Immunodeficiency Virus (HIV) is a potential precursor to Acquired Immune Deficiency Syndrome (AIDS), which commonly treated with a mixture of reverse transcriptase inhibitors (RTI) and protease inhibitors (PI). AdaDocID: 1pbRe - View Document | |
New Zealand Consumer Medicine Information Viramune Tablets and Oral Suspension NevirapineDocID: 1gvCL - View Document | |
Viramune Tablets Viramune Oral Suspension Nevirapine Consumer Medicine InformationDocID: 1gtrY - View Document | |
ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOLDocID: 1fNy0 - View Document |